B12/MIC combines vitamin B12 with three lipotropic compounds (Methionine, Inositol, and Choline) which help support fat metabolism, liver detox, and energy production
The FDA is proposing to exclude semaglutide, tirzepatide, and liraglutide on the 503B bulks list, which identifies bulk drug substances that outsourcing facilities may use in compounding when there is a clinical need
HDAC9 inhibition enhances TFEB acetylation and nuclear localization, increasing the transcription of lysosomal genes such as LAMP1 and CTSD and improving AD-related phenotypes in vivo
Florou, P., Anagnostis, P., Theocharis, P., Chourdakis, M., & Goulis, D
Ideal candidates typically include those who have struggled with traditional dieting, have insulin resistance or prediabetes, or need to lose 15 or more pounds